OOIR: Observatory of International Research

Papers

(The median citation count of Therapeutic Advances in Musculoskeletal Disease is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Actigraphy-derived physical activity levels and circadian rhythm parameters in patients with psoriatic arthritis: relationship with disease activity, mood, age and BMI	67
Is there wastage in the research resources for ankylosing spondylitis? An analysis of clinical trial discontinuation and nonpublication outcome	40
The socioeconomic status of patients with ankylosing spondylitis and its association with the burden of the disease and permanent disability: a cross-sectional cluster analysis	36
An update on the use of conventional and biological disease-modifying anti-rheumatic drugs in hand osteoarthritis	34
Anti-sclerostin antibodies: a new frontier in fragility fractures treatment	29
Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients	26
Cardio-rheumatology: integrated care and the opportunities for personalized medicine	26
Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset	24
Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension	24
Similarities and differences: disentangling the intersection between axial psoriatic arthritis and axial spondyloarthritis	24
From advanced imaging to molecular insights: the state of the art in omics for axial spondyloarthritis	19
The association between glucagon-like peptide-1 receptor agonist and rheumatoid arthritis: a population-based case–control study	18
Reduced bone mineral density in patients with idiopathic inflammatory myopathies: a case-control study	17
The challenge of pharmacotherapy for musculoskeletal pain: an overview of unmet needs	16
Plain language summary: gout remission with pegloticase	15
Dipeptidyl peptidase-4 inhibitors are associated with a lower risk of osteoarthritis in patients with type 2 diabetes	14
The association between gout flares and monosodium urate burden assessed using musculoskeletal ultrasound in patients with gout	14
Early knee OA definition–what do we know at this stage? An imaging perspective	14
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosi	13
Effects of acupuncture versus placebo on clinical status and potential specific effects in Fibromyalgia: an umbrella review of 11 meta-analyses	13
T-score discordance between hip and lumbar spine: risk factors and clinical implications	12
Role of imaging for eligibility and safety of a-NGF clinical trials	12
Intramuscular methylprednisolone administration in hand osteoarthritis patients: a feasibility study to inform a randomized controlled trial	12
Psoriatic arthritis management: a comparative analysis of PANLAR, EULAR, and GRAPPA treatment recommendations	11
Treatment with adalimumab in patients with chronic inflammatory rheumatic diseases: a study of treatment trajectories on a patient level in routine care	11

A transfer learning–based approach for automated bone fracture classification in X-ray imaging	11
Systemic lupus erythematosus is associated with increased risk of Parkinson’s disease	11
Advanced imaging techniques in crystal arthritis	11
Development and evaluation of a multivariable prediction model for clinical improvement in an established cohort of Colombian rheumatoid arthritis patients	10
Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis	10
A novel infrapatellar approach of ultrasound-guided intra-articular injection of the knee from both lateral and medial side: a case series	9
Gout therapy updated	9
Safety, tolerability, and efficacy of the PD-1 agonist antibody JNJ-67484703 in adults with active rheumatoid arthritis: results of a multicenter, double-blind, placebo-controlled, randomized, multipl	9
Implementation of clinical decision support tools for treatment selection in knee osteoarthritis: a scoping review	9
Mechanisms hypothesized for pain-relieving effects of exercise in fibromyalgia: a scoping review	9
Bone marrow edema in children: chronic nonbacterial osteomyelitis and its mimickers	9
The analysis of the pulmonary domain involvement in Sjögren’s disease	8
Precision medicine in axial spondyloarthritis: current opportunities and future perspectives	8
Precision medicine using molecular-target drugs in psoriatic arthritis	7
Medication holidays in osteoporosis: evidence-based recommendations from the Italian guidelines on ‘Diagnosis, risk stratification, and continuity of care of fragility fractures’ based on a systematic	7
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy	7
The application of machine learning in early diagnosis of osteoarthritis: a narrative review	6
Latest insights in disease-modifying osteoarthritis drugs development	6
Ultrasound evaluation of finger joint cartilage damage progression in patients with rheumatoid arthritis	6
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)	6
Effects of adipose-derived mesenchymal stem cell conditioned medium on human tenocytes exposed to high glucose	6
Muscle health in ankylosing spondylitis: effects of disease duration, inflammation, education level, and spinal mobility on skeletal muscle atrophy	6
Achievement of higher thresholds of clinical responses and lower levels of disease activity is associated with improvements in workplace and household productivity in patients with axial spondyloarthr	6
Associations of muscle mass, adipose tissue mass, and skeletal muscle radiodensity with disease activity in axial spondyloarthritis	6
Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab	5
Meibomian gland dropout of upper eyelids as a novel biomarker for early diagnosis of primary Sjögren’s syndrome: a pilot study	5
The association between glucagon-like peptide-1 receptor agonists and reported musculoskeletal adverse events: a systematic review and meta-analysis of randomized controlled trials	5
Evaluation of hematological parameters as biomarkers of disease activity in drug-naïve patients with rheumatoid arthritis: a retrospective analysis	5
Impact of obesity on clinical outcomes and treatment continuation in rheumatoid arthritis patients receiving non-TNF-targeted therapies	5
Tofacitinib in early active axial spondyloarthritis: protocol of a randomized double-blind, placebo-controlled, multicenter phase IV study, FASTLANE	5
Bone fragility during the COVID-19 pandemic: the role of macro- and micronutrients	5
Definition of the terms used to describe psoriatic disease datasets: a HIPPOCRATES initiative	4
Association between impaired lung function and risk of spondyloarthritis: a cross-sectional study in the UK Biobank	4
The impact of psoriatic arthritis on quality of life: a systematic review	4
The burden of low back pain in children and adolescents with overweight and obesity: from pathophysiology to prevention and treatment strategies	4
SCORE2 is superior to SCORE in predicting the presence of carotid plaques and intima-media thickness in rheumatoid arthritis patients: a cross-sectional study using carotid ultrasound	4
Orthopaedic physicians’ awareness, diagnostic challenges and referral barriers in axial spondyloarthritis: insights from a nationwide survey in Germany	4
Natural language processing to intercept rheumatoid and psoriatic arthritis from clinical notes in the Emergency Department	4
To flare or not to flare: patients’ and rheumatologists’ perceptions on the on-flare retreatment strategy of rituximab in rheumatoid arthritis	4
Advancing artificial intelligence in rheumatology from evidence to practice	4
Vertebral fractures and bone health in patients with chronic non-bacterial osteomyelitis at disease onset: insights from the monocentric CAMELOT cohort	3
Effectiveness of high-frequency repetitive transcranial magnetic stimulation combined with quadriceps strength training in the treatment of knee osteoarthritis: a randomized controlled trial	3
Comparison of clinical efficiency between intra-articular injection of platelet-rich plasma and hyaluronic acid for osteoarthritis: a meta-analysis of randomized controlled trials	3
Incidence rate of and risk factors for glomerulonephritis in patients with axial spondyloarthritis: a nationwide population-based study	3
RAGing ahead in rheumatology: new language model architectures to tame artificial intelligence	3
Identifying global trends from case reports of fibrodysplasia ossificans progressiva: a scoping review	3
Monotherapy or combination therapy in PsA: current aspects	3
Innovations in Genicular Outcomes Registry (IGOR): protocol for a real-world registry study of treatments for knee osteoarthritis	3
Risk factors for acute coronary syndrome in patients with giant cell arteritis: a scoping review	3
A procedure in decline: frequency of temporal artery biopsies since 2017 in a major Danish ophthalmology center	3

New insights in lower limb reconstruction strategies	3
A prognostic immune nutritional index can predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis	3
Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis	3
Double positivity for anti-dsDNA and anti-Sm antibodies represents higher disease activity in systemic lupus erythematosus	3
Capsular stem cell function and tissue composition are associated with symptoms and radiographic severity in people with knee osteoarthritis	3
Clinical characteristics of myositis patients with isolated anti-U1 ribonucleoprotein antibody resemble immune-mediated necrotizing myopathy	3
Impact of csDMARDs adherence on clinical remission in patients with new-onset inflammatory arthritis: a prospective cohort study from the ELECTRA database	3
Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exp	3
The clinical phenotype of anti-Th/To+ patients in systemic sclerosis: a case-control study within the European Scleroderma Trials and Research cohort	3
Retraction notice	3
The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthri	3
Imaging-guided stratification in giant cell arteritis: prognostic and therapeutic implications	3
Effects of TNF-α inhibition versus secukinumab on active ultrasound-confirmed enthesitis in psoriatic arthritis	3
Patient and public involvement in musculoskeletal pain research: using mutual learning to improve research quality	3
The neutrophil-to-lymphocyte ratio as a surrogate marker for disease activity in systemic lupus erythematosus: a correlation study using the SLE-DAS	2
Consensus statements on the transition care for adolescents with rheumatic diseases in Saudi Arabia	2
Early-stage hypertension defined by the 2017 ACC/AHA blood pressure guideline carries excessive cardiovascular risk in axial spondyloarthritis patients	2
Major adverse cardiovascular events or venous thromboembolism in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a nationwide, pop	2
Deep learning meets chest X-rays: a promising approach for predicting future compression fracture risk	2
Clinical and immunological long-term outcomes after autologous hematopoietic stem cell transplantation in systemic sclerosis: a retrospective single-center experience	2
Tracking global quality of life trajectories in knee osteoarthritis: a population-based long-term analysis	2
Utilising a non-surgical intervention in the knee osteoarthritis care pathway: a 6-year retrospective audit on NHS patients	2
Efficacy and safety of small molecule oral medications for psoriatic arthritis: a network meta-analysis of randomized controlled trials	2
Malignancy risk in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a 5-year population-based cohort study	2
Cost-effectiveness of specialised manual therapy versus orthopaedic care for musculoskeletal disorders: long-term follow-up and health economic model	2
Investigating the relationship between osteoporosis and rheumatoid arthritis: prospective cohort study and genetic analyses	2
Persistence of IL-17 and TNF inhibitors following initial TNF inhibitor use in axial spondyloarthritis: a nationwide retrospective cohort study	2
Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib	2
Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance	2
The protocol for a patient-driven online prospective European observational cohort aiming to determine risk factors for the development of psoriatic arthritis among people living with psoriasis: the H	2
Primary non-response in inflammatory arthritis treated with biologics and targeted therapies in daily clinical practice	2
The role of radiography and MRI as screening tools and outcome measures in clinical trials of knee osteoarthritis: a perspective on the current status and outlook	2
Uveitis in paediatric Behçet disease: a large multicentric Italian cohort	2
Risk factors and prognosis of depression in Takayasu arteritis patients	2
Regenerative medicine for early osteoarthritis	2
Cardiovascular comorbidities in psoriatic arthritis: state of the art	2
Diagnosis and therapeutic management of psoriatic arthritis: summary of 2024 update of the Spanish clinical practice guideline (ESPOGUIA)	2
Switching from rituximab originator to GP2013 or CT-P10 biosimilars in autoimmune rheumatic diseases: drug retention rate and safety data from a multicentric retrospective cohort	2
Serum transthyretin levels and disease activity in patients with primary Sjögren’s syndrome	2